---
category: listing
circular_id: f6368e1bc4464493
date: '2025-08-26'
description: BSE announces listing of 91,86,490 equity shares of Suven Life Sciences
  Ltd issued through preferential allotment with warrant conversion, effective August
  28, 2025.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={E193254A-D087-4E73-BD70-6BA9BE83F6ED}&noticeno=20250826-32&dt=08/26/2025&icount=32&totcount=60&flag=0
impact: low
impact_ranking: low
importance_ranking: low
justification: Routine listing of new equity shares through warrant conversion with
  minimal market impact
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20250826-32&attachedId=
processing:
  attempts: 1
  content_hash: d80a5777c580df00
  processed_at: '2025-08-26T18:36:43.106955'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-08-26T12:03:01+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={E193254A-D087-4E73-BD70-6BA9BE83F6ED}&noticeno=20250826-32&dt=08/26/2025&icount=32&totcount=60&flag=0
severity: low
source: bse
stocks:
- SUVEN
tags:
- listing
- equity-shares
- preferential-allotment
- warrant-conversion
- suven-life-sciences
title: Listing of New Securities of Suven Life Sciences Ltd
---

## Summary

BSE has announced the listing and trading permission for 91,86,490 new equity shares of Suven Life Sciences Ltd (Scrip Code: 530239) effective from Thursday, August 28, 2025. These shares were issued at a premium through preferential allotment pursuant to warrant conversion.

## Key Points

- 91,86,490 equity shares of Rs. 1/- each issued at premium of Rs. 133/-
- Issued to Non Promoters on preferential basis through warrant conversion
- Shares rank pari-passu with existing equity shares
- Distribution Numbers: 218073718 to 227260207
- Issue Price: Rs. 134/-
- ISIN: INE495B01038

## Regulatory Changes

No regulatory changes announced in this circular.

## Compliance Requirements

- Trading members are informed of the new securities listing
- Lock-in period applies until March 9, 2026 for all issued shares

## Important Dates

- Allotment Date: July 16, 2025
- Trading Commencement: August 28, 2025
- Lock-in Expiry: March 9, 2026

## Impact Assessment

Minimal market impact expected as this is a routine listing of shares issued through warrant conversion. The lock-in period until March 2026 prevents immediate trading of these shares, limiting any potential dilution effect on existing shareholders.